Population pharmacokinetics of midazolam and its metabolites in overweight and obese adolescents
A van Rongen, JD Vaughns, GS Moorthy… - British journal of …, 2015 - Wiley Online Library
Aim In view of the increasing prevalence of obesity in adolescents, the aim of this study was
to determine the pharmacokinetics of the CYP3A substrate midazolam and its metabolites in …
to determine the pharmacokinetics of the CYP3A substrate midazolam and its metabolites in …
[HTML][HTML] Population pharmacokinetics of midazolam and its metabolites in overweight and obese adolescents
A van Rongen, JD Vaughns, GS Moorthy… - British Journal of …, 2015 - ncbi.nlm.nih.gov
Aim In view of the increasing prevalence of obesity in adolescents, the aim of this study was
to determine the pharmacokinetics of the CYP3A substrate midazolam and its metabolites in …
to determine the pharmacokinetics of the CYP3A substrate midazolam and its metabolites in …
Population pharmacokinetics of midazolam and its metabolites in overweight and obese adolescents
A Rongen, JD Vaughns, GS Moorthy, JS Barrett… - British Journal of Clinical …, 2015 - infona.pl
Aim In view of the increasing prevalence of obesity in adolescents, the aim of this study was
to determine the pharmacokinetics of the CYP3A substrate midazolam and its metabolites in …
to determine the pharmacokinetics of the CYP3A substrate midazolam and its metabolites in …
Population pharmacokinetics of midazolam and its metabolites in overweight and obese adolescents.
A van Rongen, JD Vaughns, GS Moorthy… - British Journal of …, 2015 - europepmc.org
Aim In view of the increasing prevalence of obesity in adolescents, the aim of this study was
to determine the pharmacokinetics of the CYP3A substrate midazolam and its metabolites in …
to determine the pharmacokinetics of the CYP3A substrate midazolam and its metabolites in …
Population pharmacokinetics of midazolam and its metabolites in overweight and obese adolescents
A van Rongen, JD Vaughns, GS Moorthy… - British Journal of …, 2015 - repub.eur.nl
Aim In view of the increasing prevalence of obesity in adolescents, the aim of this study was
to determine the pharmacokinetics of the CYP3A substrate midazolam and its metabolites in …
to determine the pharmacokinetics of the CYP3A substrate midazolam and its metabolites in …
Population pharmacokinetics of midazolam and its metabolites in overweight and obese adolescents.
A Rongen, JD Vaughns, GS Moorthy… - British Journal of …, 2015 - search.ebscohost.com
Aim In view of the increasing prevalence of obesity in adolescents, the aim of this study was
to determine the pharmacokinetics of the CYP3A substrate midazolam and its metabolites in …
to determine the pharmacokinetics of the CYP3A substrate midazolam and its metabolites in …
Population pharmacokinetics of midazolam and its metabolites in overweight and obese adolescents.
A Rongen, JD Vaughns, GS Moorthy, JS Barrett… - 2015 - cabidigitallibrary.org
AIM: In view of the increasing prevalence of obesity in adolescents, the aim of this study was
to determine the pharmacokinetics of the CYP3A substrate midazolam and its metabolites in …
to determine the pharmacokinetics of the CYP3A substrate midazolam and its metabolites in …
Population pharmacokinetics of midazolam and its metabolites in overweight and obese adolescents
A van Rongen, JD Vaughns… - British journal of …, 2015 - pubmed.ncbi.nlm.nih.gov
Aim In view of the increasing prevalence of obesity in adolescents, the aim of this study was
to determine the pharmacokinetics of the CYP3A substrate midazolam and its metabolites in …
to determine the pharmacokinetics of the CYP3A substrate midazolam and its metabolites in …
[引用][C] Population pharmacokinetics of midazolam and its metabolites in overweight and obese adolescents.
A van Rongen, JD Vaughns… - British Journal of …, 2015 - hsrc.himmelfarb.gwu.edu
"Population pharmacokinetics of midazolam and its metabolites in overwe" by Anne van Rongen,
Janelle D. Vaughns et al. Home Search Browse Collections My Account About DC Network …
Janelle D. Vaughns et al. Home Search Browse Collections My Account About DC Network …
Population pharmacokinetics of midazolam and its metabolites in overweight and obese adolescents.
A van Rongen, JD Vaughns, GS Moorthy… - British Journal of …, 2015 - europepmc.org
Aim In view of the increasing prevalence of obesity in adolescents, the aim of this study was
to determine the pharmacokinetics of the CYP3A substrate midazolam and its metabolites in …
to determine the pharmacokinetics of the CYP3A substrate midazolam and its metabolites in …